BiBBInstruments AB (BIBB.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 0.399 (+5.00%) as of
Key statistics
- Market cap
- 64.23M
- EPS (TTM)
- -0.2600
- Dividend yield
- 0.00%
- 52-week range
- 0.3100 – 3.9900
- Beta
- 1.40
- Revenue (TTM)
- 947k
- Profit margin
- 0.00%
- Analyst target
- SEK 0.67
- Volume
- 426.82k
About BiBBInstruments AB
BiBBInstruments AB, a medical technology company, develops and markets electrically powered endoscopic biopsy systems in the United States and Europe. The company offers EndoDrill which enables tissue sampling, with the aim of improving diagnostics in several common cancers, including those affecting the pancreas, stomach, liver, lungs, and urinary bladder. It also provides EndoDrill GI which used for endoscopic ultrasound; EndoDrill EBUS is used in the airways during endobronchial ultrasound (EBUS); and EndoDrill URO that is used with a standard cystoscope for sampling of muscle-invasive bladder cancer. The company was incorporated in 2013 and is headquartered in Lund, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Lund, Sweden
- Employees
- 4
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.